Surveillance Activities. 1. Aerial surveillance activities during the withdrawal will be carried out as follows:
Surveillance Activities. 7.1 The Client agrees to cooperate and facilitate the surveillance activities as laid down in the certification requirements.
Surveillance Activities. Coordinated the epidemiology and laboratory sectors of both the MOH and veterinary authorities to improve national risk assessment for avian influenza and other zoonotic diseases. • Conducted multiple field investigations for communicable diseases, assessing both the epidemiologic and environmental situation in various governorates. • Conducted field visits to monitor influenza A (H5N1) virus national surveillance sites and provide on-the-job training. • Established unified database for acute respiratory illness (ARI) and influenza surveillance. • Provided reports online for sentinel surveillance sites (ILI/SARI). • Improved diagnostic capacity of the subnational laboratories. • Expanded geographical representativeness of influenza surveillance, early detection, and improved diagnosis, including the capacity for influenza virus subtyping in cooperation with the NIC and Vacsera.
Surveillance Activities. Established a sampling scheme to ensure the validity of inferences regarding the burden of influenza. • Conducted training workshops to enhance the skills of health workers in sampling specimens. • Strengthened the surveillance system with the addition of seven SARI sites in 2014, including one pediatric site.
Surveillance Activities. (a) All products certified by NIJ shall be enrolled in the applicable NIJ CTP Surveillance. NIJ CTP Surveillance activities may consist of any one or combination of the following:
Surveillance Activities. Reviewed the status of influenza virological surveillance in the African region from 2010 to 2013. Results were published in the November 2014 edition of the Integrated Disease Surveillance and Response quarterly bulletin. • Worked with the respective governments of Burundi and Mauritania to conduct an assessment of their influenza surveillance systems (July/ August 2014). The assessment revealed that both countries do not have functional virological and epidemiological influenza surveillance systems in place. • Attended the 4th African Network Influenza Surveillance and Epidemiology (ANISE) Meeting held in Cape Town, South Africa (5–6 Dec 2014) and chaired a session on “Setting the Stage for Influenza Vaccine Introduction” during this meeting.
Surveillance Activities. Analyzed influenza surveillance data from different partners and determined the temporal trends of influenza activity in the country as well as circulating virus types and sub-types. • Analyzed influenza surveillance data to determine potential optimal timing of a possible seasonal influenza vaccine campaign.
Surveillance Activities. Assembled a project focused on surveillance at three pig farms to explore the human-animal interface. • Completed the influenza-specific SARI project in October 2013 and implemented a general SARI surveillance system. • Managed ILI and SARI surveillance, including sampling and analysis. • Organized the 4th Annual Meeting for SARI site managers in Antananarivo (July 2014). The discussion focused on coordination and standardization of data collection (clinical illness and mortality) of malaria and SARI throughout sentinel hospitals. LABORATORY Madagascar’s NIC enhanced its diagnosis and technical capacities by implementing rRT-PCR allelic discrimination analysis for detection of the substitution conferring influenza A(H1N1)pdm09 viruses resistant to oseltamivir. We also implemented the influenza virus microneutralization assay according to CDC’s protocol. The NIC also worked closely with CDC Atlanta and South Africa in collaboration with the Association of Public Health Laboratories (APHL) to implement an international training on rRT-PCR for influenza diagnosis, gathering technicians and scientists from 18 African countries, including participants from Madagascar’s NIC. LABORATORY ACTIVITIES • Tested 2,583 specimens for influenza diagnosis between October 1, 2013 and April 19, 2015. Among all specimens, 311 were SARI cases that were tested at the NIC using an in-house panel system for the detection of respiratory viruses. Submitted 32 positive isolates and 34 positive swabs to the WHO Collaborating Center (CC) in London as part of the WHO Global Influenza Programme. • Completed the WHO External Quality Assessment Project (EQAP) Panel 13. • Investigated a bronchiolitis epidemic in Antananarivo in a children’s hospital in early March; results highlighted RSV and human metapneumovirus infections in 67% of specimens collected. PREPAREDNESS CDC support allowed the NIC to strengthen both ILI and SARI surveillance systems. All fever sentinel hospital sites participated in a meeting in July 2014 to coordinate and standardize data collection (clinical illness and mortality) of SARI data. High-risk events vary widely in scope and nature but share one common characteristic: how well we manage these critical events relies heavily on how well we communicate before, during, and after these events. Training on Risk Communication, held in Mauritius in December 2014, helped us to understand the process of risk communication and provided tools for informed decision-making an...
Surveillance Activities. Trained sentinel site staff on influenza case definition, sample collection, and shipment. • Developed a centralized database to integrate clinical and laboratory data. • Performed regular supervisory visits to influenza sentinel sites in Sikasso and Mopti (monthly) and Bamako (weekly). • Collected samples and case report forms from sentinel sites in Sikasso and Mopti and sent them to the NIC. • Shared weekly reports with sentinel sites, the Ministry of Health, CDC, and WHO Country Office, and entered information into FluNet.
Surveillance Activities. Collected data and developed a protocol and data collection tools for estimates of burden of disease for medically-attended influenza. • Conducted eight quarterly supervisory visits to the sentinel sites. • Investigated and confirmed two suspected outbreaks of ILI and SARI due to influenza A (H1N1)pdm09 virus. HIGHLIGHTS • Shipped samples to a WHO Collaborating Center (CC) for the first time. • Performed characterization of other respiratory pathogens for the first time using RT-PCR Multiplex. • Completed manuscript summarizing six years of influenza surveillance in Rwanda. • Performed antigenic characterization of influenza viruses circulating in Rwanda for the first time and identified their relation to the annual influenza vaccine compositions. • Reviewed the Integrated Disease Surveillance and Response (IDSR) framework to include both ILI and SARI case definitions according to WHO’s new case definitions.
